Your browser doesn't support javascript.
loading
Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter data.
Chlebus, Krzysztof; Cybulska, Barbara; Dobrowolski, Piotr; Romanowska-Kocejko, Marzena; Zarczynska-Buchowiecka, Marta; Gilis-Malinowska, Natasza; Strózyk, Aneta; Borowiec-Wolna, Justyna; Pajkowski, Marcin; Bobrowska, Beata; Rajtar-Salwa, Renata; Kwapiszewska, Aleksandra; Walus-Miarka, Malgorzata; Chmara, Magdalena; Galaska, Rafal; Malecki, Maciej; Zdrojewski, Tomasz; Gruchala, Marcin.
Afiliación
  • Chlebus K; 1st Department of Cardiology, Medical University of Gdansk, Poland. Chlebus@gumed.edu.pl.
  • Cybulska B; National Center for Familial Hypercholesterolemia, University Clinical Center, Gdansk, Poland. Chlebus@gumed.edu.pl.
  • Dobrowolski P; National Institute of Public Health - National Institute of Hyg iene, Warsaw, Poland.
  • Romanowska-Kocejko M; Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.
  • Zarczynska-Buchowiecka M; National Center for Familial Hypercholesterolemia, University Clinical Center, Gdansk, Poland.
  • Gilis-Malinowska N; Department of Cardiac Diagnostics, Medical University of Gdansk, Poland.
  • Strózyk A; National Center for Familial Hypercholesterolemia, University Clinical Center, Gdansk, Poland.
  • Borowiec-Wolna J; Department of Cardiac Diagnostics, Medical University of Gdansk, Poland.
  • Pajkowski M; 1st Department of Cardiology, Medical University of Gdansk, Poland.
  • Bobrowska B; National Center for Familial Hypercholesterolemia, University Clinical Center, Gdansk, Poland.
  • Rajtar-Salwa R; 1st Department of Cardiology, Medical University of Gdansk, Poland.
  • Kwapiszewska A; National Center for Familial Hypercholesterolemia, University Clinical Center, Gdansk, Poland.
  • Walus-Miarka M; 1st Department of Cardiology, Medical University of Gdansk, Poland.
  • Chmara M; National Center for Familial Hypercholesterolemia, University Clinical Center, Gdansk, Poland.
  • Galaska R; National Center for Familial Hypercholesterolemia, University Clinical Center, Gdansk, Poland.
  • Malecki M; Department of Cardiac Diagnostics, Medical University of Gdansk, Poland.
  • Zdrojewski T; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.
  • Gruchala M; Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland.
Cardiol J ; 29(1): 62-71, 2022.
Article en En | MEDLINE | ID: mdl-35146730
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proproteína Convertasa 9 / Hiperlipoproteinemia Tipo II Tipo de estudio: Clinical_trials / Diagnostic_studies / Evaluation_studies Límite: Adult / Humans País/Región como asunto: Europa Idioma: En Revista: Cardiol J Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proproteína Convertasa 9 / Hiperlipoproteinemia Tipo II Tipo de estudio: Clinical_trials / Diagnostic_studies / Evaluation_studies Límite: Adult / Humans País/Región como asunto: Europa Idioma: En Revista: Cardiol J Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia